Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
Recruiting in Palo Alto (17 mi)
+194 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Shire
No Placebo Group
Trial Summary
What is the purpose of this trial?
Patients who have been treated with Fosrenol for a minimum of 12 consecutive weeks and are receiving dialysis will be followed for 5 years to compare mortality, bone fractures and incidence of selected morbidities to patients with no lanthanum exposure and to patients being treated for hyperphosphatemia with any marketed product.
Research Team
SD
Study Director
Principal Investigator
Takeda
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: Test Group
Signed informed consent
Patient must have ESRD and be receiving dialysis
See 3 more
Treatment Details
Interventions
- Lanthanum Carbonate (Fosrenol) (Phosphate Binder)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Clinical Research Center, Inc.Birmingham, AL
University of South AlabamaMobile, AL
Montgomery Kidney SpecialistsMontgomery, AL
California Kidney SpecialistCovina, CA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Shire
Lead Sponsor
Trials
457
Patients Recruited
96,000+